Skip to Content

CYP 517 (Uritact-EC 0.06 mg-81.6 mg-10.8 mg-36.2 mg)

Generic Name: hyoscyamine/methenamine/methylene blue/phenyl salicylate

Pill with imprint CYP 517 is Blue, Round and has been identified as Uritact-EC 0.06 mg-81.6 mg-10.8 mg-36.2 mg. It is supplied by Cypress Pharmaceutical Inc.

Uritact-EC is used in the treatment of urinary tract infection and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Uritact-EC 0.06 mg-81.6 mg-10.8 mg-36.2 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for CYP 517

Uritact-EC

Generic Name
hyoscyamine/methenamine/methylene blue/phenyl salicylate
Imprint
CYP 517
Strength
0.06 mg-81.6 mg-10.8 mg-36.2 mg
Color
Blue
Shape
Round
Availability
Prescription only
Drug Class
Urinary antispasmodics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Cypress Pharmaceutical Inc
National Drug Code (NDC)
60258-0517

Get help with Imprint Code FAQs.

More about Uritact-EC (hyoscyamine / methenamine / methylene blue / phenyl salicylate)

Related treatment guides

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.